LJPC La Jolla Pharmaceutical

La Jolla Pharmaceutical Co is an American biopharmaceutical company. It is focused on the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  25,556,239
Average volume:  53,542
Market cap:   $81,524,402
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   15.21
PB ratio:   -5.13
PS ratio:   1.57
Return on equity:   -7.44%
Net income %:   10.08%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy